scispace - formally typeset
A

Anna Demartis

Researcher at Schering-Plough

Publications -  14
Citations -  749

Anna Demartis is an academic researcher from Schering-Plough. The author has contributed to research in topics: Receptor & Interleukin-6 receptor. The author has an hindex of 9, co-authored 14 publications receiving 717 citations. Previous affiliations of Anna Demartis include Centre national de la recherche scientifique.

Papers
More filters
Journal ArticleDOI

Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance

TL;DR: It is reported here that CNTF and leptin activate a similar pattern of STAT factors in neuronal cells, and that mRNAs for CNTF receptor subunits, similarly to the mRNA of leptin receptor, are localized in mouse hypothalamic nuclei involved in the regulation of energy balance.
Journal ArticleDOI

Rational design of a receptor super-antagonist of human interleukin-6.

TL;DR: The demonstration of functionally independent receptor binding sites on IL‐6 suggests that it could be possible to design super‐antagonists of other helical cytokines which drive the assembly of structurally related multisubunit receptor complexes.
Journal ArticleDOI

Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites.

TL;DR: The level of trans‐activation observed with the natural promoter containing both HNF‐1 binding sites is far greater than the level of mutated variants containing only one of the two sites, which strongly suggests that two H NF‐1 molecules bound simultaneously to sites distant from each other can act synergistically to activate gene expression.
Journal ArticleDOI

Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure

TL;DR: Results demonstrate that gene electrotransfer can be applied to produce therapeutically significant levels of erythropoietin in chronic renal failure.
Journal Article

Interleukin 6 Receptor Superantagonists Are Potent Inducers of Human Multiple Myeloma Cell Death

TL;DR: IL-6 receptor antagonists are pro-apoptotic factors for the IL-6-dependent human myeloma cell line XG-1 and their capacity to induce cell death is in direct relation to their affinity for IL- 6R alpha, degree of gp130 binding impairment, and efficiency to inhibit intracellular signaling events.